{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T05:05:40Z","timestamp":1780549540336,"version":"3.54.1"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"vor","delay-in-days":44,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Cancer Institute"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"DOI":"10.1186\/s12890-026-04292-1","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T08:18:04Z","timestamp":1776759484000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of particulate matter 2.5 on a mouse model of lung adenocarcinoma"],"prefix":"10.1186","volume":"26","author":[{"given":"Elif Irmak","family":"Bektas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aftab","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Senchanthisai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyamananda Singh","family":"Mayengbam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Mackey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Spitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shamshad","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boyko","family":"Atanassov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Goodrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasenjit","family":"Dey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,21]]},"reference":[{"key":"4292_CR1","doi-asserted-by":"publisher","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12-49. https:\/\/doi.org\/10.3322\/caac.21820.","DOI":"10.3322\/caac.21820"},{"key":"4292_CR2","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/s41571-023-00798-3","volume":"20","author":"A Leiter","year":"2023","unstructured":"Leiter A, Veluswamy RR, Wisnivesky JP. The global burden of lung cancer: current status and future trends. Nat Rev Clin Oncol. 2023;20:624\u201339. https:\/\/doi.org\/10.1038\/s41571-023-00798-3.","journal-title":"Nat Rev Clin Oncol"},{"key":"4292_CR3","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/nrc2190","volume":"7","author":"S Sun","year":"2007","unstructured":"Sun S, Schiller JH, Gazdar AF. Lung cancer in never smokers\u2014a different disease. Nat Rev Cancer. 2007;7:778\u201390.","journal-title":"Nat Rev Cancer"},{"key":"4292_CR4","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1038\/s41588-021-00920-0","volume":"53","author":"T Zhang","year":"2021","unstructured":"Zhang T, et al. Genomic and evolutionary classification of lung cancer in never smokers. Nat Genet. 2021;53:1348\u201359.","journal-title":"Nat Genet"},{"key":"4292_CR5","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/s41571-023-00844-0","volume":"21","author":"J LoPiccolo","year":"2024","unstructured":"LoPiccolo J, Gusev A, Christiani DC, J\u00e4nne PA. Lung cancer in patients who have never smoked\u2014an emerging disease. Nat Rev Clin Oncol. 2024;21:121\u201346.","journal-title":"Nat Rev Clin Oncol"},{"key":"4292_CR6","doi-asserted-by":"publisher","first-page":"692008","DOI":"10.3389\/fmed.2021.692008","volume":"8","author":"K Fongsodsri","year":"2021","unstructured":"Fongsodsri K, et al. Particulate matter 2.5 and hematological disorders from dust to diseases: a systematic review of available evidence. Front Med (Lausanne). 2021;8:692008.","journal-title":"Front Med (Lausanne)"},{"key":"4292_CR7","doi-asserted-by":"publisher","first-page":"3594","DOI":"10.1038\/s41467-021-23853-y","volume":"12","author":"EE McDuffie","year":"2021","unstructured":"McDuffie EE, et al. Source sector and fuel contributions to ambient PM2. 5 and attributable mortality across multiple spatial scales. Nat Commun. 2021;12:3594.","journal-title":"Nat Commun"},{"key":"4292_CR8","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1016\/j.jtho.2021.06.015","volume":"16","author":"R Myers","year":"2021","unstructured":"Myers R, et al. High-ambient air pollution exposure among never smokers versus ever smokers with lung cancer. J Thorac Oncol. 2021;16:1850\u20138. https:\/\/doi.org\/10.1016\/j.jtho.2021.06.015.","journal-title":"J Thorac Oncol"},{"key":"4292_CR9","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1016\/S0140-6736(17)30505-6","volume":"389","author":"AJ Cohen","year":"2017","unstructured":"Cohen AJ, et al. Estimates and 25-year trends of the global burden of disease attributable to ambient air pollution: an analysis of data from the Global Burden of Diseases Study 2015. Lancet. 2017;389:1907\u201318.","journal-title":"Lancet"},{"key":"4292_CR10","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s41586-023-05874-3","volume":"616","author":"W Hill","year":"2023","unstructured":"Hill W, et al. Lung adenocarcinoma promotion by air pollutants. Nature. 2023;616:159\u201367. https:\/\/doi.org\/10.1038\/s41586-023-05874-3.","journal-title":"Nature"},{"key":"4292_CR11","doi-asserted-by":"publisher","unstructured":"Hamra GB, Guha N, Cohen A, Laden F, Raaschou-Nielsen O, Samet JM, Vineis P, Forastiere F, Saldiva P, Yorifuji T, Loomis D. Outdoor particulate matter exposure and lung cancer: a systematic review and meta-analysis. Environ Health Perspect. 2014;122(9):906\u201311. https:\/\/doi.org\/10.1289\/ehp\/1408092.","DOI":"10.1289\/ehp\/1408092"},{"key":"4292_CR12","doi-asserted-by":"crossref","unstructured":"Berg CD, Schiller JH, Boffetta P, Cai J, Connolly C, Kerpel-Fronius A, Kitts AB, Lam DC, Mohan A, Myers R, Suri T. Air pollution and lung cancer: a review by international association for the study of lung cancer early detection and screening committee. J Thorac Oncol. 2023;18(10):1277\u201389.","DOI":"10.1016\/j.jtho.2023.05.024"},{"key":"4292_CR13","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1093\/jnci\/dji055","volume":"97","author":"H Shigematsu","year":"2005","unstructured":"Shigematsu H, et al. Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers. J Natl Cancer Inst. 2005;97:339\u201346.","journal-title":"J Natl Cancer Inst"},{"key":"4292_CR14","doi-asserted-by":"publisher","first-page":"eabq0615","DOI":"10.1126\/sciadv.abq0615","volume":"8","author":"C-Y Chang","year":"2022","unstructured":"Chang C-Y, et al. Chronic exposure to carbon black ultrafine particles reprograms macrophage metabolism and accelerates lung cancer. Sci Adv. 2022;8:eabq0615.","journal-title":"Sci Adv"},{"key":"4292_CR15","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1111\/cea.13178","volume":"48","author":"K De Grove","year":"2018","unstructured":"De Grove K, Provoost S, Brusselle G, Joos G, Maes T. Insights in particulate matter\u2010induced allergic airway inflammation: focus on the epithelium. Clin Exp Allergy. 2018;48:773\u201386.","journal-title":"Clin Exp Allergy"},{"key":"4292_CR16","unstructured":"Bao ZJ, Fan YM, Cui YF, Sheng YF, Zhu M. Effect of PM2.5 mediated oxidative stress on the innate immune cellular response of Der p1 treated human bronchial epithelial cells. European Review for Medical and Pharmacological Sciences. 2017;21(12):2907\u201312."},{"key":"4292_CR17","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1126\/science.1221064","volume":"337","author":"B Pulendran","year":"2012","unstructured":"Pulendran B, Artis D. New paradigms in type 2 immunity. Science. 2012;337:431\u20135.","journal-title":"Science"},{"key":"4292_CR18","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/s41577-020-0301-x","volume":"20","author":"WC Gause","year":"2020","unstructured":"Gause WC, Rothlin C, Loke P. Heterogeneity in the initiation, development and function of type 2 immunity. Nat Rev Immunol. 2020;20:603\u201314.","journal-title":"Nat Rev Immunol"},{"key":"4292_CR19","doi-asserted-by":"publisher","first-page":"4311","DOI":"10.4049\/jimmunol.181.6.4311","volume":"181","author":"HK Jessup","year":"2008","unstructured":"Jessup HK, et al. Intradermal administration of thymic stromal lymphopoietin induces a T cell-and eosinophil-dependent systemic Th2 inflammatory response. J Immunol. 2008;181:4311\u20139.","journal-title":"J Immunol"},{"key":"4292_CR20","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.immuni.2013.07.018","volume":"39","author":"T Mchedlidze","year":"2013","unstructured":"Mchedlidze T, et al. Interleukin-33-dependent innate lymphoid cells mediate hepatic fibrosis. Immunity. 2013;39:357\u201371.","journal-title":"Immunity"},{"key":"4292_CR21","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1016\/j.jaci.2014.05.011","volume":"134","author":"D Li","year":"2014","unstructured":"Li D, et al. IL-33 promotes ST2-dependent lung fibrosis by the induction of alternatively activated macrophages and innate lymphoid cells in mice. J Allergy Clin Immunol. 2014;134:1422-1432. e1411.","journal-title":"J Allergy Clin Immunol"},{"key":"4292_CR22","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/nri.2017.90","volume":"18","author":"RL Gieseck III","year":"2018","unstructured":"Gieseck RL III, Wilson MS, Wynn TA. Type 2 immunity in tissue repair and fibrosis. Nat Rev Immunol. 2018;18:62\u201376.","journal-title":"Nat Rev Immunol"},{"key":"4292_CR23","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1073\/pnas.1315854111","volume":"111","author":"E Hams","year":"2014","unstructured":"Hams E, et al. IL-25 and type 2 innate lymphoid cells induce pulmonary fibrosis. Proc Natl Acad Sci U S A. 2014;111:367\u201372.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4292_CR24","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ccell.2022.01.003","volume":"40","author":"A Alam","year":"2022","unstructured":"Alam A, et al. Fungal mycobiome drives IL-33 secretion and type 2 immunity in pancreatic cancer. Cancer Cell. 2022;40:153-167. e111.","journal-title":"Cancer Cell"},{"key":"4292_CR25","doi-asserted-by":"publisher","first-page":"eabn0175","DOI":"10.1126\/sciimmunol.abn0175","volume":"7","author":"E Jou","year":"2022","unstructured":"Jou E, et al. An innate IL-25\u2013ILC2\u2013MDSC axis creates a cancer-permissive microenvironment for Apc mutation\u2013driven intestinal tumorigenesis. Sci Immunol. 2022;7:eabn0175.","journal-title":"Sci Immunol"},{"key":"4292_CR26","doi-asserted-by":"publisher","unstructured":"Bahhar I, E\u015f Z, K\u00f6se O, Turna A, G\u00fcnl\u00fco\u011flu MZ, \u00c7ak\u0131r A, Dural\u0131 D, Magnusson FC. The IL-25\/ILC2 axis promotes lung cancer with a concomitant accumulation of immune-suppressive cells in tumors in humans and mice. Front Immunol. 2023;14:1244437. https:\/\/doi.org\/10.3389\/fimmu.2023.1244437.","DOI":"10.3389\/fimmu.2023.1244437"},{"key":"4292_CR27","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/s41586-020-2938-9","volume":"587","author":"NC Henderson","year":"2020","unstructured":"Henderson NC, Rieder F, Wynn TA. Fibrosis: from mechanisms to medicines. Nature. 2020;587:555\u201366.","journal-title":"Nature"},{"key":"4292_CR28","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.ecoenv.2018.07.076","volume":"163","author":"R Zheng","year":"2018","unstructured":"Zheng R, et al. NLRP3 inflammasome activation and lung fibrosis caused by airborne fine particulate matter. Ecotoxicol Environ Saf. 2018;163:612\u20139.","journal-title":"Ecotoxicol Environ Saf"},{"key":"4292_CR29","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3390\/jcm10010077","volume":"10","author":"S Majewski","year":"2020","unstructured":"Majewski S, Piotrowski WJ. Air pollution\u2014an overlooked risk factor for idiopathic pulmonary fibrosis. J Clin Med. 2020;10:77.","journal-title":"J Clin Med"},{"key":"4292_CR30","doi-asserted-by":"publisher","unstructured":"Kim C, Jeong SH, Lee H, Nam YJ, Lee H, Choi JY, Lee YS, Kim J, Park YH, Lee JH. Subchronic particulate matter exposure underlying polyhexamethylene guanidine phosphate-induced lung injury: Quantitative and qualitative evaluation with chest computed tomography. Heliyon. 2024;10(14):e34562. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e34562.","DOI":"10.1016\/j.heliyon.2024.e34562"},{"key":"4292_CR31","doi-asserted-by":"publisher","first-page":"22672","DOI":"10.1038\/s41598-021-02140-2","volume":"11","author":"C Kim","year":"2021","unstructured":"Kim C, et al. Evaluation of the effect of filtered ultrafine particulate matter on bleomycin-induced lung fibrosis in a rat model using computed tomography, histopathologic analysis, and RNA sequencing. Sci Rep. 2021;11:22672.","journal-title":"Sci Rep"},{"key":"4292_CR32","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.ecoenv.2018.12.061","volume":"171","author":"XZ Xu ZiHan","year":"2019","unstructured":"Xu ZiHan XZ, et al. PM2.5 induced pulmonary fibrosis in vivo and in vitro. Ecotoxicol Environ Saf. 2019;171:112\u201321.","journal-title":"Ecotoxicol Environ Saf"},{"key":"4292_CR33","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.trsl.2019.02.006","volume":"209","author":"C Chandler","year":"2019","unstructured":"Chandler C, Liu T, Buckanovich R, Coffman LG. The double edge sword of fibrosis in cancer. Transl Res. 2019;209:55\u201367.","journal-title":"Transl Res"},{"key":"4292_CR34","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/j.ccell.2021.09.003","volume":"39","author":"H Hu","year":"2021","unstructured":"Hu H, et al. Three subtypes of lung cancer fibroblasts define distinct therapeutic paradigms. Cancer Cell. 2021;39:1531-1547. e1510.","journal-title":"Cancer Cell"},{"key":"4292_CR35","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1101\/gad.1417406","volume":"20","author":"K Politi","year":"2006","unstructured":"Politi K, et al. Lung adenocarcinomas induced in mice by mutant EGF receptors foundin human lung cancers respondto a tyrosine kinase inhibitor orto down-regulation of the receptors. Genes Dev. 2006;20:1496\u2013510.","journal-title":"Genes Dev"},{"key":"4292_CR36","doi-asserted-by":"publisher","first-page":"4257","DOI":"10.1007\/s00216-016-9519-7","volume":"408","author":"MM Schantz","year":"2016","unstructured":"Schantz MM, et al. Development of two fine particulate matter standard reference materials (< 4 \u03bcm and< 10 \u03bcm) for the determination of organic and inorganic constituents. Anal Bioanal Chem. 2016;408:4257\u201366.","journal-title":"Anal Bioanal Chem"},{"key":"4292_CR37","doi-asserted-by":"publisher","first-page":"L424","DOI":"10.1152\/ajplung.00232.2019","volume":"317","author":"YL Chan","year":"2019","unstructured":"Chan YL, et al. Pulmonary inflammation induced by low-dose particulate matter exposure in mice. Am J Physiol Lung Cell Mol Physiol. 2019;317:L424\u201330.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"4292_CR38","doi-asserted-by":"publisher","first-page":"eadh8005","DOI":"10.1126\/scitranslmed.adh8005","volume":"15","author":"BH Herzog","year":"2023","unstructured":"Herzog BH, et al. Tumor-associated fibrosis impairs immune surveillance and response to immune checkpoint blockade in non\u2013small cell lung cancer. Sci Transl Med. 2023;15:eadh8005.","journal-title":"Sci Transl Med"},{"key":"4292_CR39","doi-asserted-by":"publisher","first-page":"101563","DOI":"10.1016\/j.xpro.2022.101563","volume":"3","author":"A Alam","year":"2022","unstructured":"Alam A, Comer S, Levanduski E, Dey P. Isolation and adoptive transfer of innate lymphoid cells 2 to a recipient mouse model of PDAC. STAR Protoc. 2022;3:101563.","journal-title":"STAR Protoc"},{"key":"4292_CR40","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1158\/0008-5472.can-03-3376","volume":"64","author":"AY Nikitin","year":"2004","unstructured":"Nikitin AY, et al. Classification of proliferative pulmonary lesions of the mouse: recommendations of the mouse models of human cancers consortium. Cancer Res. 2004;64:2307\u201316. https:\/\/doi.org\/10.1158\/0008-5472.can-03-3376.","journal-title":"Cancer Res"},{"key":"4292_CR41","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1038\/s41590-020-0802-6","volume":"21","author":"T Suzuki","year":"2020","unstructured":"Suzuki T, Hidaka T, Kumagai Y, Yamamoto M. Environmental pollutants and the immune response. Nat Immunol. 2020;21:1486\u201395.","journal-title":"Nat Immunol"},{"key":"4292_CR42","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.freeradbiomed.2020.01.179","volume":"151","author":"DA Glencross","year":"2020","unstructured":"Glencross DA, Ho T-R, Camina N, Hawrylowicz CM, Pfeffer PE. Air pollution and its effects on the immune system. Free Radic Biol Med. 2020;151:56\u201368.","journal-title":"Free Radic Biol Med"},{"key":"4292_CR43","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.jaci.2016.03.044","volume":"139","author":"KC De Grove","year":"2017","unstructured":"De Grove KC, et al. Dysregulation of type 2 innate lymphoid cells and TH2 cells impairs pollutant-induced allergic airway responses. J Allergy Clin Immunol. 2017;139:246-257. e244.","journal-title":"J Allergy Clin Immunol"},{"key":"4292_CR44","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.3390\/ijerph16132347","volume":"16","author":"B Estrella","year":"2019","unstructured":"Estrella B, et al. Effects of air pollution on lung innate lymphoid cells: review of in vitro and in vivo experimental studies. Int J Environ Res Public Health. 2019;16:2347.","journal-title":"Int J Environ Res Public Health"},{"key":"4292_CR45","doi-asserted-by":"publisher","first-page":"690375","DOI":"10.3389\/fimmu.2021.690375","volume":"12","author":"F Huaux","year":"2021","unstructured":"Huaux F. Interpreting immunoregulation in lung fibrosis: a new branch of the immune model. Front Immunol. 2021;12:690375.","journal-title":"Front Immunol"},{"key":"4292_CR46","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1159\/000073718","volume":"132","author":"A Saito","year":"2003","unstructured":"Saito A, Okazaki H, Sugawara I, Yamamoto K, Takizawa H. Potential action of IL-4 and IL-13 as fibrogenic factors on lung fibroblasts in vitro. Int Arch Allergy Immunol. 2003;132:168\u201376.","journal-title":"Int Arch Allergy Immunol"},{"key":"4292_CR47","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1165\/ajrcmb.18.1.2627","volume":"18","author":"A Hancock","year":"1998","unstructured":"Hancock A, Armstrong L, Gama R, Millar A. Production of interleukin 13 by alveolar macrophages from normal and fibrotic lung. Am J Respir Cell Mol Biol. 1998;18:60\u20135.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"4292_CR48","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.1016\/j.biocel.2008.02.016","volume":"40","author":"LA Murray","year":"2008","unstructured":"Murray LA, et al. Hyper-responsiveness of IPF\/UIP fibroblasts: interplay between TGF\u03b21, IL-13 and CCL2. Int J Biochem Cell Biol. 2008;40:2174\u201382.","journal-title":"Int J Biochem Cell Biol"},{"key":"4292_CR49","doi-asserted-by":"publisher","first-page":"614","DOI":"10.3346\/jkms.2009.24.4.614","volume":"24","author":"S-W Park","year":"2009","unstructured":"Park S-W, et al. Interleukin-13 and its receptors in idiopathic interstitial pneumonia: clinical implications for lung function. J Korean Med Sci. 2009;24:614\u201320.","journal-title":"J Korean Med Sci"},{"key":"4292_CR50","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1165\/rcmb.2013-0342OC","volume":"50","author":"LA Murray","year":"2014","unstructured":"Murray LA, et al. Targeting interleukin-13 with tralokinumab attenuates lung fibrosis and epithelial damage in a humanized SCID idiopathic pulmonary fibrosis model. Am J Respir Cell Mol Biol. 2014;50:985\u201394.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"4292_CR51","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/nrc1877","volume":"6","author":"R Kalluri","year":"2006","unstructured":"Kalluri R, Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer. 2006;6:392\u2013401.","journal-title":"Nat Rev Cancer"},{"key":"4292_CR52","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.ccell.2023.12.021","volume":"42","author":"L Cords","year":"2024","unstructured":"Cords L, et al. Cancer-associated fibroblast phenotypes are associated with patient outcome in non-small cell lung cancer. Cancer Cell. 2024;42:396-412. e395.","journal-title":"Cancer Cell"},{"key":"4292_CR53","doi-asserted-by":"publisher","first-page":"6707","DOI":"10.1007\/s13277-014-1908-y","volume":"35","author":"Y Chen","year":"2014","unstructured":"Chen Y, et al. Transforming growth factor-\u03b21 and \u03b1-smooth muscle actin in stromal fibroblasts are associated with a poor prognosis in patients with clinical stage I-IIIA nonsmall cell lung cancer after curative resection. Tumor Biol. 2014;35:6707\u201313.","journal-title":"Tumor Biol"},{"key":"4292_CR54","doi-asserted-by":"crossref","unstructured":"Cortez E, Roswall P, Pietras K. Functional subsets of mesenchymal cell types in the tumor microenvironment. Semin Cancer Biol. 2014;25:3\u20139.","DOI":"10.1016\/j.semcancer.2013.12.010"},{"key":"4292_CR55","doi-asserted-by":"crossref","unstructured":"Paulsson J, Micke P. Prognostic relevance of cancer-associated fibroblasts in human cancer. Semin Cancer Biol. 2014;25:61\u20138.","DOI":"10.1016\/j.semcancer.2014.02.006"},{"key":"4292_CR56","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1097\/JTO.0b013e3181834f52","volume":"3","author":"T Donnem","year":"2008","unstructured":"Donnem T, et al. Prognostic impact of platelet-derived growth factors in non-small cell lung cancer tumor and stromal cells. J Thorac Oncol. 2008;3:963\u201370.","journal-title":"J Thorac Oncol"},{"key":"4292_CR57","doi-asserted-by":"publisher","first-page":"6478","DOI":"10.1038\/s41598-017-06922-5","volume":"7","author":"MJ Schliekelman","year":"2017","unstructured":"Schliekelman MJ, et al. Thy-1+ cancer-associated fibroblasts adversely impact lung cancer prognosis. Sci Rep. 2017;7:6478.","journal-title":"Sci Rep"},{"key":"4292_CR58","doi-asserted-by":"publisher","first-page":"5552","DOI":"10.4049\/jimmunol.178.9.5552","volume":"178","author":"MR Nazareth","year":"2007","unstructured":"Nazareth MR, et al. Characterization of human lung tumor-associated fibroblasts and their ability to modulate the activation of tumor-associated T cells. J Immunol. 2007;178:5552\u201362.","journal-title":"J Immunol"},{"key":"4292_CR59","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1158\/1541-7786.MCR-10-0497","volume":"9","author":"JD Roybal","year":"2011","unstructured":"Roybal JD, et al. miR-200 Inhibits lung adenocarcinoma cell invasion and metastasis by targeting Flt1\/VEGFR1. Mol Cancer Res. 2011;9:25\u201335.","journal-title":"Mol Cancer Res"},{"key":"4292_CR60","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s10020-023-00616-7","volume":"29","author":"F Zeng","year":"2023","unstructured":"Zeng F, et al. Role and mechanism of CD90+ fibroblasts in inflammatory diseases and malignant tumors. Mol Med. 2023;29:20.","journal-title":"Mol Med"},{"key":"4292_CR61","doi-asserted-by":"publisher","first-page":"5554","DOI":"10.1007\/s11356-013-2468-1","volume":"21","author":"L Alessandria","year":"2014","unstructured":"Alessandria L, Schilir\u00f2 T, Degan R, Traversi D, Gilli G. Cytotoxic response in human lung epithelial cells and ion characteristics of urban-air particles from Torino, a northern Italian city. Environ Sci Pollut Res. 2014;21:5554\u201364.","journal-title":"Environ Sci Pollut Res"},{"key":"4292_CR62","doi-asserted-by":"publisher","first-page":"9940","DOI":"10.1007\/s11356-018-1262-5","volume":"25","author":"C Dou","year":"2018","unstructured":"Dou C, Zhang J, Qi C. Cooking oil fume-derived PM2. 5 induces apoptosis in A549 cells and MAPK\/NF-\u043aB\/STAT1 pathway activation. Environ Sci Pollut Res Int. 2018;25:9940\u20138.","journal-title":"Environ Sci Pollut Res Int"},{"key":"4292_CR63","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1007\/s11356-012-1157-9","volume":"20","author":"S Pavagadhi","year":"2013","unstructured":"Pavagadhi S, Betha R, Venkatesan S, Balasubramanian R, Hande MP. Physicochemical and toxicological characteristics of urban aerosols during a recent Indonesian biomass burning episode. Environ Sci Pollut Res. 2013;20:2569\u201378.","journal-title":"Environ Sci Pollut Res"},{"key":"4292_CR64","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1016\/j.scitotenv.2017.05.107","volume":"599","author":"J Yan","year":"2017","unstructured":"Yan J, et al. Industrial PM2. 5 cause pulmonary adverse effect through RhoA\/ROCK pathway. Sci Total Environ. 2017;599:1658\u201366.","journal-title":"Sci Total Environ"},{"key":"4292_CR65","first-page":"749","volume":"35","author":"A Craver","year":"2024","unstructured":"Craver A, et al. Air quality and cancer risk in the All of Us Research Program. Cancer Causes Control. 2024;35:749\u201360.","journal-title":"Cancer Causes Control"},{"key":"4292_CR66","doi-asserted-by":"publisher","first-page":"143766","DOI":"10.1016\/j.chemosphere.2024.143766","volume":"368","author":"EM Quezada-Maldonado","year":"2024","unstructured":"Quezada-Maldonado EM, et al. Mutational landscape induced by chronic exposure to environmental PM10 and PM2. 5 in A549 lung epithelial cell. Chemosphere. 2024;368:143766.","journal-title":"Chemosphere"},{"key":"4292_CR67","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.mrgentox.2008.08.015","volume":"657","author":"M Mehta","year":"2008","unstructured":"Mehta M, Chen L-C, Gordon T, Rom W, Tang M-S. Particulate matter inhibits DNA repair and enhances mutagenesis. Mutat Res-Genet Toxicol Environ Mutagen. 2008;657:116\u201321.","journal-title":"Mutat Res-Genet Toxicol Environ Mutagen"},{"key":"4292_CR68","first-page":"7506","volume":"15","author":"R Li","year":"2018","unstructured":"Li R, Zhou R, Zhang J. Function of PM2. 5 in the pathogenesis of lung cancer and chronic airway inflammatory diseases. Oncol Lett. 2018;15:7506\u201314.","journal-title":"Oncol Lett"},{"key":"4292_CR69","doi-asserted-by":"publisher","unstructured":"Vu J, Nadeau K, Kasowski M. Molecular mechanisms of air pollution\u2013induced carcinogenesis and the emerging role of microplastics. Hum Genomics. 2026;20:6. https:\/\/doi.org\/10.1186\/s40246-025-00880-0.","DOI":"10.1186\/s40246-025-00880-0"},{"key":"4292_CR70","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s44321-024-00175-2","volume":"17","author":"C-Y Chen","year":"2024","unstructured":"Chen C-Y, et al. The role of PM2. 5 exposure in lung cancer: mechanisms, genetic factors, and clinical implications. EMBO Mol Med. 2024;17:31.","journal-title":"EMBO Mol Med"},{"key":"4292_CR71","doi-asserted-by":"publisher","first-page":"104329","DOI":"10.1016\/j.etap.2023.104329","volume":"105","author":"NA Craig","year":"2024","unstructured":"Craig NA, et al. Promotion of myofibroblast differentiation through repeated treatment of fibroblasts to low concentrations of PM2. 5. Environ Toxicol Pharmacol. 2024;105:104329.","journal-title":"Environ Toxicol Pharmacol"},{"key":"4292_CR72","doi-asserted-by":"publisher","first-page":"e0134965","DOI":"10.1371\/journal.pone.0134965","volume":"10","author":"TK Kilvaer","year":"2015","unstructured":"Kilvaer TK, et al. Cancer associated fibroblasts in stage I-IIIA NSCLC: prognostic impact and their correlations with tumor molecular markers. PLoS One. 2015;10:e0134965.","journal-title":"PLoS One"},{"key":"4292_CR73","doi-asserted-by":"publisher","unstructured":"Wang L, Yang H, Dorn P, Berezowska S, Blank F, Wotzkow C, Marti TM, Peng RW, Harrer N, Sommergruber W, Kocher GJ, Schmid RA, Hall SRR. Peritumoral CD90+CD73+ cells possess immunosuppressive features in human non-small cell lung cancer. EBioMedicine. 2021;73:103664. https:\/\/doi.org\/10.1016\/j.ebiom.2021.103664.","DOI":"10.1016\/j.ebiom.2021.103664"},{"key":"4292_CR74","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1158\/1541-7786.MCR-15-0307","volume":"14","author":"D Pankova","year":"2016","unstructured":"Pankova D, et al. Cancer-associated fibroblasts induce a collagen cross-link switch in tumor stroma. Mol Cancer Res. 2016;14:287\u201395.","journal-title":"Mol Cancer Res"},{"key":"4292_CR75","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/ncb2756","volume":"15","author":"F Calvo","year":"2013","unstructured":"Calvo F, et al. Mechanotransduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancer-associated fibroblasts. Nat Cell Biol. 2013;15:637\u201346.","journal-title":"Nat Cell Biol"},{"key":"4292_CR76","doi-asserted-by":"publisher","first-page":"3486","DOI":"10.3390\/cancers14143486","volume":"14","author":"D Kim","year":"2022","unstructured":"Kim D, et al. Identification and characterization of cancer-associated fibroblast subpopulations in lung adenocarcinoma. Cancers. 2022;14:3486.","journal-title":"Cancers"},{"key":"4292_CR77","doi-asserted-by":"publisher","first-page":"101264","DOI":"10.1016\/j.redox.2019.101264","volume":"26","author":"H Wang","year":"2019","unstructured":"Wang H, et al. The effect of exposure time and concentration of airborne PM2. 5 on lung injury in mice: a transcriptome analysis. Redox Biol. 2019;26:101264.","journal-title":"Redox Biol"},{"key":"4292_CR78","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.lfs.2015.10.025","volume":"152","author":"S Dutta","year":"2016","unstructured":"Dutta S, Sengupta P. Men and mice: relating their ages. Life Sci. 2016;152:244\u20138.","journal-title":"Life Sci"},{"key":"4292_CR79","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1183\/09031936.00122213","volume":"43","author":"KA Johannson","year":"2014","unstructured":"Johannson KA, et al. Acute exacerbation of idiopathic pulmonary fibrosis associated with air pollution exposure. Eur Respir J. 2014;43:1124\u201331.","journal-title":"Eur Respir J"},{"key":"4292_CR80","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1513\/AnnalsATS.202404-382OC","volume":"22","author":"C Sack","year":"2025","unstructured":"Sack C, et al. Long-term air pollution exposure and severity of idiopathic pulmonary fibrosis: data from the idiopathic pulmonary fibrosis prospective outcomes (IPF-PRO) registry. Ann Am Thorac Soc. 2025;22:378\u201386.","journal-title":"Ann Am Thorac Soc"},{"key":"4292_CR81","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s40572-021-00328-2","volume":"8","author":"CM Eckhardt","year":"2021","unstructured":"Eckhardt CM, Wu H. Environmental exposures and lung aging: molecular mechanisms and implications for improving respiratory health. Curr Environ Health Rep. 2021;8:281\u201393.","journal-title":"Curr Environ Health Rep"},{"key":"4292_CR82","doi-asserted-by":"publisher","first-page":"1324552","DOI":"10.3389\/fimmu.2024.1324552","volume":"15","author":"\u00d6 Kayalar","year":"2024","unstructured":"Kayalar \u00d6, et al. Impact of particulate air pollution on airway injury and epithelial plasticity; underlying mechanisms. Front Immunol. 2024;15:1324552.","journal-title":"Front Immunol"},{"key":"4292_CR83","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1164\/rccm.202011-4063OC","volume":"204","author":"Y Huang","year":"2021","unstructured":"Huang Y, et al. Air pollution, genetic factors, and the risk of lung cancer: a prospective study in the UK Biobank. Am J Respir Crit Care Med. 2021;204:817\u201325. https:\/\/doi.org\/10.1164\/rccm.202011-4063OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"4292_CR84","doi-asserted-by":"publisher","first-page":"E6409","DOI":"10.1073\/pnas.1613601113","volume":"113","author":"DG McFadden","year":"2016","unstructured":"McFadden DG, et al. Mutational landscape of EGFR-, MYC-, and Kras-driven genetically engineered mouse models of lung adenocarcinoma. Proc Natl Acad Sci. 2016;113:E6409\u201317.","journal-title":"Proc Natl Acad Sci"},{"key":"4292_CR85","doi-asserted-by":"publisher","first-page":"3435","DOI":"10.1158\/0008-5472.CAN-22-0325","volume":"82","author":"J Boumelha","year":"2022","unstructured":"Boumelha J, et al. An immunogenic model of KRAS-mutant lung cancer enables evaluation of targeted therapy and immunotherapy combinations. Cancer Res. 2022;82:3435\u201348.","journal-title":"Cancer Res"},{"key":"4292_CR86","doi-asserted-by":"publisher","first-page":"E10947","DOI":"10.1073\/pnas.1708391114","volume":"114","author":"W-J Chung","year":"2017","unstructured":"Chung W-J, et al. Kras mutant genetically engineered mouse models of human cancers are genomically heterogeneous. Proc Natl Acad Sci. 2017;114:E10947\u201355.","journal-title":"Proc Natl Acad Sci"},{"key":"4292_CR87","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.ccr.2010.11.011","volume":"19","author":"M DuPage","year":"2011","unstructured":"DuPage M, et al. Endogenous T cell responses to antigens expressed in lung adenocarcinomas delay malignant tumor progression. Cancer Cell. 2011;19:72\u201385.","journal-title":"Cancer Cell"},{"key":"4292_CR88","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1007\/s00262-020-02837-9","volume":"70","author":"R Salehi-Rad","year":"2021","unstructured":"Salehi-Rad R, et al. Novel Kras-mutant murine models of non-small cell lung cancer possessing co-occurring oncogenic mutations and increased tumor mutational burden. Cancer Immunol Immunother. 2021;70:2389\u2013400.","journal-title":"Cancer Immunol Immunother"},{"key":"4292_CR89","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1093\/toxsci\/55.1.24","volume":"55","author":"KE Driscoll","year":"2000","unstructured":"Driscoll KE. Intratracheal instillation as an exposure technique for the evaluation of respiratory tract toxicity: uses and limitations. Toxicol Sci. 2000;55:24\u201335.","journal-title":"Toxicol Sci"},{"key":"4292_CR90","doi-asserted-by":"publisher","first-page":"e0289373","DOI":"10.1371\/journal.pone.0289373","volume":"18","author":"K Yisrael","year":"2023","unstructured":"Yisrael K, et al. Route of administration significantly affects particle deposition and cellular recruitment. PLoS One. 2023;18:e0289373.","journal-title":"PLoS One"},{"key":"4292_CR91","doi-asserted-by":"publisher","first-page":"57","DOI":"10.4103\/ed.ed_16_18","volume":"3","author":"Y Shang","year":"2018","unstructured":"Shang Y, Sun Q. Particulate air pollution: major research methods and applications in animal models. Environ Dis. 2018;3:57\u201362.","journal-title":"Environ Dis"},{"key":"4292_CR92","unstructured":"Bein K, Franzi LM, Last J, Linderholm A, Pinkerton K. A quantitative comparison of intranasal and intratracheal administration of coarse PM in the mouse. 2015."}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-026-04292-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-026-04292-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-026-04292-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T04:35:47Z","timestamp":1780547747000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12890-026-04292-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,21]]},"references-count":92,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4292"],"URL":"https:\/\/doi.org\/10.1186\/s12890-026-04292-1","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,21]]},"assertion":[{"value":"3 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal procedures were approved by the Institutional Animal Care and Use Committee (IACUC) ethics committee at Roswell Park Comprehensive Cancer Center (protocol numbers 1416 and 1486). All experiments were performed in accordance with relevant guidelines and regulations. All animals were maintained in pathogen-free conditions and were cared for by the International Association for Assessment and Accreditation of Laboratory Animal Care policies and certification. The authors complied with the ICLAS guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"252"}}